大華繼顯:給予中滙集團(0382.HK)“買入”評級,目標價11港元
格隆匯5月11日丨大華繼顯昨日發佈研報稱,中滙集團通過成功收購兩所位於四川的學校,在2021財年有望迎來另一項強勁增長極。大華繼顯還預計公司在2022財年能夠實現更好的盈利,因為獨立學院轉設完成後有助於節省約3700萬人民幣成本。截止至2021財年上半年,中滙集團的學生總數為62400人,同比增長76.8%,平均學費為15700元,同比增長45.4%。大華繼顯恢復跟蹤覆蓋中滙集團,給予中滙集團(0382.HK)“買入”評級,目標價11港元,較今日收盤價7.86港元存在約40%的潛在漲幅。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.